Back to top
more

Baxter International (BAX)

(Delayed Data from NYSE)

$26.50 USD

26.50
5,186,518

+0.21 (0.80%)

Updated Aug 26, 2026 04:00 PM ET

After-Market: $26.47 -0.03 (-0.11%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.80%
2Buy18.13%
3Hold10.19%
4Sell5.73%
5Strong Sell3.17%
S&P50011.53%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

B Value B Growth C Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 40% (100 out of 247)

Industry: Medical - Products

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

Senseonics Stock Down Despite New FDA Approval for Eversense 365

by Zacks Equity Research

SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.

Indrajit Bandyopadhyay headshot

4 Medical Product Stocks to Buy From a Prospective Industry

by Indrajit Bandyopadhyay

Ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, BAX, HAE and PAHC are well-poised to gain from the favorable factors.

Zacks Equity Research

Here's Why You Should Retain Integer Holdings Stock in Your Portfolio Now

by Zacks Equity Research

ITGR's research and product development activities raise optimism about the stock. Rising demand for its products bodes well for the company.

Zacks Equity Research

MMSI Stock Likely to Gain From Cook Medical's Product Portfolio Buyout

by Zacks Equity Research

Merit Medical expects to solidify its foothold in the underpenetrated global lead management market via the latest asset acquisition.

Zacks Equity Research

MASI Stock Gains as US Court Raises Concern About Politan's Ethics

by Zacks Equity Research

Shares of Masimo have risen since the news of a court ruling against Politan. The ruling is likely to favor MASI's founder in the upcoming vote for new board members on Sept. 19.

Zacks Equity Research

Stryker Stock Declines Despite Completion of care.ai Acquisition

by Zacks Equity Research

SYK completes the acquisition of care.ai, adding AI-based workflows and smart room technology to its portfolio to overcome nursing shortages, and improve staff retention and workplace safety.

Zacks Equity Research

Masimo's Stock Up Following the New Tie-Up With Google to Boost Wear OS

by Zacks Equity Research

MASI's latest partnership is likely to develop a new reference platform that brings high-performing Wear OS smartwatches to market.

Zacks Equity Research

ARAY Stock Up Following the Use of SGRT on Cancer Patients in Japan

by Zacks Equity Research

The latest adoption of Accuray's Radixact System and VitalHold package is likely to improve the care provided to cancer patients and their experience.

Zacks Equity Research

Baxter (BAX) Upgraded to Buy: Here's Why

by Zacks Equity Research

Baxter (BAX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Zacks Equity Research

BAX vs. PODD: Which Stock Should Value Investors Buy Now?

by Zacks Equity Research

BAX vs. PODD: Which Stock Is the Better Value Option?